₩19810.00
₩-20.00 (-0.10%)
End-of-day quote: 05/13/2024
KOSE:A005500
Samjin Pharmaceuticals Annual Report
| Year | Year | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
₩0.00M | ₩0.00M | ₩0.00M | ₩0.00M | ₩0.00M | ₩0.00M | ₩0.00M | ₩0.00M | ||
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||
| EPS | Earnings Per Share |
|
₩0.00 | ₩2.27k | ₩2.27k | ₩917.00 | ₩2.08k | ₩2.89k | ₩2.42k | ₩2.17k | ₩1.66k | ₩627.00 |
| Div. | Dividends |
|
₩0.00 | ₩0.00 | ₩800.00 | ₩800.00 | ₩700.00 | ₩600.00 | ₩500.00 | ₩400.00 | ||
| PR % | Payout Ratio % |
|
0 | 0 | 38.55% | 27.67% | 28.89% | 27.62% | 30.05% | 63.80% | ||
| Sha. | Shares |
|
12.45m | 12.45m | 12.45m | 12.45m | 12.45m | 12.45m | 12.45m | 12.45m | ||
| OCF | Operating Cash Flow |
|
₩0.00M | ₩0.00M | ₩0.00M | ₩0.00M | ₩0.00M | ₩0.00M | ₩0.00M | ₩0.00M | ||
| FCF | Free Cash Flow |
|
₩0.00M | ₩0.00M | ₩22.16B | ₩28.42B | ₩40.86B | ₩11.27B | ₩21.80B | ₩0.00M | ||
| FCFS | Free Cash Flow Per Share |
|
₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 |
